Revance Therapeutics (RVNC) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Revance Therapeutics (RVNC) Misses Q4 EPS by 1c

Revance Therapeutic (RVNC) PT Raised to $32 at Goldman Sachs

February 20, 2020 6:09 AM EST

Goldman Sachs analyst Terence Flynn raised the price target on Revance Therapeutic (NASDAQ: RVNC) to $32.00 (from $25.00) while maintaining a Buy rating.... More